Cigna Group (CI) Competitors $295.91 -4.04 (-1.35%) As of 11:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CI vs. CNC, ELV, HCA, HUM, UNH, MOH, SEM, JYNT, AEMD, and NVSShould you be buying Cigna Group stock or one of its competitors? The main competitors of Cigna Group include Centene (CNC), Elevance Health (ELV), HCA Healthcare (HCA), Humana (HUM), UnitedHealth Group (UNH), Molina Healthcare (MOH), Select Medical (SEM), Joint (JYNT), Aethlon Medical (AEMD), and Novartis (NVS). These companies are all part of the "medical" sector. Cigna Group vs. Its Competitors Centene Elevance Health HCA Healthcare Humana UnitedHealth Group Molina Healthcare Select Medical Joint Aethlon Medical Novartis Cigna Group (NYSE:CI) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Does the media prefer CI or CNC? In the previous week, Centene had 32 more articles in the media than Cigna Group. MarketBeat recorded 61 mentions for Centene and 29 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.55 beat Centene's score of 0.48 indicating that Cigna Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cigna Group 25 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive Centene 19 Very Positive mention(s) 2 Positive mention(s) 35 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more risk and volatility, CI or CNC? Cigna Group has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Do insiders and institutionals hold more shares of CI or CNC? 87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.7% of Cigna Group shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is CI or CNC more profitable? Cigna Group has a net margin of 1.92% compared to Centene's net margin of 1.15%. Cigna Group's return on equity of 18.80% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Cigna Group1.92% 18.80% 5.02% Centene 1.15%9.57%3.10% Which has stronger earnings and valuation, CI or CNC? Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCigna Group$259.42B0.30$3.43B$18.3216.12Centene$163.07B0.09$3.31B$4.047.01 Do analysts prefer CI or CNC? Cigna Group currently has a consensus target price of $374.82, suggesting a potential upside of 26.90%. Centene has a consensus target price of $42.20, suggesting a potential upside of 48.92%. Given Centene's higher probable upside, analysts clearly believe Centene is more favorable than Cigna Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cigna Group 0 Sell rating(s) 2 Hold rating(s) 15 Buy rating(s) 2 Strong Buy rating(s) 3.00Centene 1 Sell rating(s) 13 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.12 SummaryCigna Group beats Centene on 14 of the 17 factors compared between the two stocks. Get Cigna Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CI vs. The Competition Export to ExcelMetricCigna GroupMED IndustryMedical SectorNYSE ExchangeMarket Cap$78.95B$41.18B$5.75B$21.23BDividend Yield2.01%68.84%3.95%3.53%P/E Ratio16.159.9630.8729.21Price / Sales0.301.70464.9753.33Price / Cash7.948.7337.7623.64Price / Book1.952.3110.185.36Net Income$3.43B$2.64B$3.27B$996.59M7 Day Performance-1.88%-1.58%2.95%2.79%1 Month Performance1.07%8.94%4.16%2.66%1 Year Performance-17.48%-34.29%45.06%12.51% Cigna Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CICigna Group5 of 5 stars$295.91-1.3%$374.82+26.7%-15.2%$78.93B$259.42B16.1471,300Positive NewsAnalyst ForecastCNCCentene4.8463 of 5 stars$28.99+1.8%$42.20+45.6%-63.0%$14.24B$163.07B7.1860,500Trending NewsAnalyst ForecastELVElevance Health4.8901 of 5 stars$310.03+0.1%$413.81+33.5%-43.6%$69.81B$177.01B13.19104,200Positive NewsHCAHCA Healthcare4.6258 of 5 stars$393.86-0.5%$398.58+1.2%+3.8%$92.16B$72.70B16.56316,000Positive NewsAnalyst ForecastHUMHumana4.1774 of 5 stars$287.75+0.5%$281.43-2.2%-15.9%$34.61B$117.76B22.0865,680Positive NewsDividend AnnouncementUNHUnitedHealth Group4.9473 of 5 stars$308.84+1.6%$367.71+19.1%-48.3%$279.71B$422.82B13.38400,000Analyst ForecastAnalyst RevisionHigh Trading VolumeMOHMolina Healthcare4.9436 of 5 stars$169.48+1.2%$242.91+43.3%-49.7%$9.19B$43.41B8.3518,000Analyst ForecastGap UpSEMSelect Medical4.9985 of 5 stars$12.92+1.6%$24.60+90.4%-63.1%$1.60B$5.19B12.1944,100Positive NewsJYNTJoint4.0468 of 5 stars$10.55-3.1%$16.33+54.8%-4.7%$161.84M$51.90M-31.97320Positive NewsHigh Trading VolumeAEMDAethlon Medical2.5197 of 5 stars$1.17+2.6%$56.00+4,686.3%-58.2%$3.04MN/A-0.0910NVSNovartis1.8291 of 5 stars$123.96-0.2%$123.50-0.4%+5.9%$261.86B$50.32B18.0475,883Positive News Related Companies and Tools Related Companies Centene Alternatives Elevance Health Alternatives HCA Healthcare Alternatives Humana Alternatives UnitedHealth Group Alternatives Molina Healthcare Alternatives Select Medical Alternatives Joint Alternatives Aethlon Medical Alternatives Novartis Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CI) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cigna Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Cigna Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access